JY
SBBP

Jeff Yass’s Strongbridge Biopharma plc. SBBP Stock Holding History

Jeff Yass’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-155,457
Closed -$317K – 14509
2021
Q3 		$317K Buy
155,457
+117,568
+310% +$274K ﹤0.01% 10482
2021
Q2 		$113K Sell
37,889
-9,887
-21% -$26.1K ﹤0.01% 12032
2021
Q1 		$132K Buy
47,776
+29,901
+167% +$90.2K ﹤0.01% 11725
2020
Q4 		$43K Buy
17,875
+4,484
+33% +$10.8K ﹤0.01% 10784
2020
Q3 		$28K Buy
+13,391
New +$45.1K ﹤0.01% 10343
2020
Q2 		– Sell
-10,223
Closed -$30.6K – 11310
2020
Q1 		$19K Sell
10,223
-5,095
-33% -$13.2K ﹤0.01% 9948
2019
Q4 		$32K Sell
15,318
-2,921
-16% -$5.6K ﹤0.01% 9430
2019
Q3 		$44K Sell
18,239
-64,988
-78% -$175K ﹤0.01% 9815
2019
Q2 		$261K Buy
+83,227
New +$306K ﹤0.01% 8595
2018
Q3 		– Sell
-82,924
Closed -$498K – 10604
2018
Q2 		$498K Buy
+82,924
New +$607K ﹤0.01% 6796

Jeff Yass's SBBP Position: Q4 2021 in Review

Jeff Yass sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 155,457 shares — an estimated $317K sold.

Jeff Yass first reported a position in SBBP in Q2 2018 and held it in 10 quarters. The position peaked at $498K in Q2 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Jeff Yass reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Jeff Yass sold 155,457 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $317K.
  • Jeff Yass first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 10 quarters.
  • Jeff Yass's Strongbridge Biopharma plc. position peaked at $498K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.